A comparative study on the utility of biomarkers – serum interleukin-13 against serum immunoglobulin E in assessing the severity of asthma

Dimensions

Raju, P and Sundar, S and Suresh, P and Thulukanam, J and Srinivasan, P (2025) A comparative study on the utility of biomarkers – serum interleukin-13 against serum immunoglobulin E in assessing the severity of asthma. A comparative study on the utility of biomarkers – serum interleukin-13 against serum immunoglobulin E in assessing the severity of asthma, 23(2) (445-52). ISSN 2544-1361

Text
202568.pdf - Published Version
Download (571kB)

Official URL: https://doi.org/10.15584/ejcem.2025.2.27

Abstract

Asthma is a complex respiratory condition with fluctuating symptoms, airflow obstruction, bronchial hyperresponsiveness, and inflammation. Interleukin (IL)-13 induces various biological responses, including B-cell immunoglobulin E (IgE), eosinophil chemo-attractants, and mucus-secreting goblet cell maturation. B-cell mmunoglobulin E antibodies are essential for the onset and propagation of the inflammatory cascade, triggering the allergic response. The aim was to compare the utility of biomarkers – serum IL-13 against serum IgE in assessing the severity of asthma

Affiliation:	ICMR- National Institute for Research in Tuberculosis
Item Type:	Article
URI:	http://eprints.nirt.res.in/id/eprint/2125

Actions (login required)

View Item